160 Moreover, low GSH-Px activity, in the absence of hemolysis, also is observed in normal people from New Zealand with selenium (Se) deficiency (Se being an integral part of GSH-Px)
The orientation table below is unpacked, with citations, in the sections that follow
Who should not rely on BPC-157 for alcohol protection: Anyone with diagnosed liver disease (cirrhosis, hepatitis, fatty liver disease) People with alcohol use disorder who need medical treatment, not peptide supplementation Anyone taking hepatotoxic medications (acetaminophen at high doses, certain statins, methotrexate) Individuals with bleeding disorders or on anticoagulants BPC-157 is not a substitute for medical care
However, with IBD-current biologic therapies, all these mean some patients primary non-responders, experience a loss of response, intolerance or side effects, defining the urgent unmet need for novel treatments (13, 14)
This depends on multiple factors, as everybody is unique and reacts differently to supplemental injections